Baxter sees Q4 adjusted EPS 52c-57c, consensus 70c

The company said, “The company expects sales growth from continuing operations of approximately 2% on a reported basis and a decline of approximately 2% on an operational basis. The company expects adjusted earnings from continuing operations, before special items, of $0.52 to $0.57 per diluted share.”